Alembic Pharmaceuticals Ltd
NSE:APLLTD

Watchlist Manager
Alembic Pharmaceuticals Ltd Logo
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Watchlist
Price: 913.6 INR -1.9% Market Closed
Market Cap: 179.6B INR

During the last 3 months Alembic Pharmaceuticals Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 14% over this period (open performance analysis).

The last transaction was made on Mar 17, 2022 by Alembic Limited (Chairman) , who bought 28.5m INR worth of APLLTD shares.

Last Transactions:
Alembic Limited
Chairman
â‚ą+28.5m
Shreno Engineering Limited
Managing Director
â‚ą+70.8k
Alembic Limited
Chairman
â‚ą+14.5m
Alembic Limited
Chairman
â‚ą+49.7m
Alembic Limited
Chairman
â‚ą+97.7m
Mr. Chirayu Ramanbhai Amin As Managing Trustee On Behalf Of Cra
Managing Trustee
â‚ą+78.3k
Bhailal Amin General Hospital
Managing Trustee
â‚ą-188m
Uday Education Society
â‚ą-187.1m
Alembic Limited
Chairman
â‚ą+266.6m
Uday Education Society
Non-Executive Director
â‚ą-376.2m
Bhailal Amin General Hospital
Managing Trustee
â‚ą-75.4m
Salome Pranav Parikh
Non-Executive Independent Director
â‚ą+511.7k
Maya Parikh Verma
Senior Vice President - Human Resources & Corporate Communications
â‚ą+511k
Shelina Pranav Parikh
Non-Executive Director
â‚ą+500.6k
Salome Pranav Parikh
Non-Executive Independent Director
â‚ą+500.6k
Maya Pranav Parikh
Director
â‚ą+500.6k
Chirayu Ramanbhai Amin
Chairman
â‚ą+2.9m
Chirayu Ramanbhai Amin
Chairman
â‚ą+17.4m
Uday Education Society
Non-Executive Director
â‚ą-184.4m
Uday Education Society
Non-Executive Director
â‚ą-143.8m
Uday Education Society
Non-Executive Director
â‚ą-36.9m
Uday Education Society
Non-Executive Director
â‚ą-24.7m
Shreno Limited
Managing Director
â‚ą+54.5k
Barkha Pranav Amin
Non-Executive Director
â‚ą+54.6k
Krupa Shaunak Amin
Chief Financial Officer
â‚ą+54.6k
Alembic City Limited
Director
â‚ą+51.9k
Grace Star Trust
â‚ą+52.2k
Satori Trust
â‚ą+52.1k
Gallup Trust
â‚ą+52.1k
Shreno Publications Limited
â‚ą+51.9k
Laksh Trust
Trustee
â‚ą+52.2k
Yeraben Ramanbhai Amin
Non-Executive Director
â‚ą-253.2k
View All Transactions

During the last 3 months Alembic Pharmaceuticals Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 14% over this period (open performance analysis).

The last transaction was made on Mar 17, 2022 by Alembic Limited (Chairman) , who bought 28.5m INR worth of APLLTD shares.

Sold
0-3
months
0 INR
0
3-6
months
0 INR
0
6-9
months
0 INR
0
9-12
months
0 INR
0
Bought
0-3
months
No Insider Transactions
0
0 INR
3-6
months
No Insider Transactions
0
0 INR
6-9
months
No Insider Transactions
0
0 INR
9-12
months
No Insider Transactions
0
0 INR

Alembic Pharmaceuticals Ltd
Insider Trading Chart

Alembic Pharmaceuticals Ltd
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Alembic Pharmaceuticals Ltd
Last Insider Transactions

Global
Insiders Monitor

Alembic Pharmaceuticals Ltd
Glance View

Market Cap
182.8B INR
Industry
Pharmaceuticals

Alembic Pharmaceuticals Ltd., with roots tracing back over a hundred years, began as a modest tincture and alcohol company in Vadodara, India. Its journey from crafting everyday remedies to becoming a stalwart in the pharmaceutical industry exemplifies ambition intertwined with tradition. Today, Alembic stands as a formidable entity, specializing in the research, development, manufacturing, and sale of active pharmaceutical ingredients (APIs) and generic formulations. The company thrives on a blend of innovation and scalability, strategically advancing its manufacturing capabilities while adhering to stringent quality standards. This commitment has not only bolstered its domestic stronghold but also enabled it to penetrate highly regulated international markets, such as the United States and Europe. The company's revenue model is anchored on an extensive portfolio that addresses therapeutic areas ranging from cardiovascular and anti-diabetics to respiratory and anti-infective products. By leveraging its robust R&D infrastructure, Alembic consistently introduces new and complex generics, amplifying its offerings while navigating the generic drug pricing pressures. Their vertically integrated operations ensure cost efficiency and control over API supplies, easing supply chain constraints and fortifying their competitive position. Additionally, strategic partnerships and investments in advanced manufacturing technologies have augmented its capability to meet global demands, cementing Alembic’s reputation as a reliable partner in the pharmaceutical landscape. This multifaceted approach not only expands its business horizons but firmly establishes Alembic as a key player in addressing global healthcare needs.

APLLTD Intrinsic Value
961.47 INR
Undervaluation 5%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top